Literature DB >> 21499971

Epidemiology of Streptococcus pneumoniae in France before introduction of the PCV-13 vaccine.

N Grall1, O Hurmic, M Al Nakib, M Longo, C Poyart, M-C Ploy, E Varon, J Raymond.   

Abstract

The purpose of this article was to describe the serotype incidence and antibiotic susceptibility of Streptococcus pneumoniae strains isolated from adults and children with invasive disease (IPD) or acute otitis media (AOM) before introduction of the 13-valent pneumococcal vaccine. During 2009, 494 strains of S. pneumoniae isolated were collected. Complete serotyping by latex antisera and molecular methods was performed. The most frequent serotypes isolated from children with IPD were 1 (26.2%), 19A (25%) and 7F (14.3%). Serotype 19A was predominant (42.1%) in children ≤ 2 years, whereas serotype 1 was predominant (63.3%) after the age of 5. Serotype 19A was the most frequently isolated serotype from AOM (62.3%). In adults, serotypes responsible for IPD were 7F (19.4%), 19A (13.7%), 1 (8.4%) and 3 (7.5%). The serotype 19A was predominant in adults older than 65 years (19.1%). The emergence of serotype 12F was observed in adults. Between 2007 and 2009, the introduction of PCV-7 has resulted in a significant decrease of IPD caused by serotypes included in the vaccine, in children as well as in adults, confirming the herd effect. Serotype coverage of PCV-13 was 70% and 80.9% for adult and children's IPD, respectively. PCV-13 will be more efficient in preventing invasive diseases among children and adults.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21499971     DOI: 10.1007/s10096-011-1251-9

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  36 in total

1.  Invasive pneumococcal disease a decade after pneumococcal conjugate vaccine use in an American Indian population at high risk for disease.

Authors:  Robert Weatherholtz; Eugene V Millar; Lawrence H Moulton; Raymond Reid; Karen Rudolph; Mathuram Santosham; Katherine L O'Brien
Journal:  Clin Infect Dis       Date:  2010-05-01       Impact factor: 9.079

2.  Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States.

Authors:  Rekha Pai; Matthew R Moore; Tamara Pilishvili; Robert E Gertz; Cynthia G Whitney; Bernard Beall
Journal:  J Infect Dis       Date:  2005-11-01       Impact factor: 5.226

3.  Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.

Authors:  Cynthia G Whitney; Monica M Farley; James Hadler; Lee H Harrison; Nancy M Bennett; Ruth Lynfield; Arthur Reingold; Paul R Cieslak; Tamara Pilishvili; Delois Jackson; Richard R Facklam; James H Jorgensen; Anne Schuchat
Journal:  N Engl J Med       Date:  2003-05-01       Impact factor: 91.245

4.  The epidemiology of invasive Streptococcus pneumoniae disease in Croatian children.

Authors:  Marija Guzvinec; Goran Tesović; Arjana Tambić-Andrasević; Snjezana Zidovec-Lepej; Biserka Troselj Vukić; Josip Begovac
Journal:  Med Sci Monit       Date:  2008-12

5.  Large community outbreak of Streptococcus pneumoniae serotype 5 invasive infection in an impoverished, urban population.

Authors:  Marc G Romney; Mark W Hull; Réka Gustafson; Jat Sandhu; Sylvie Champagne; Titus Wong; Anouf Nematallah; Sara Forsting; Patricia Daly
Journal:  Clin Infect Dis       Date:  2008-09-15       Impact factor: 9.079

6.  Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage.

Authors:  Rosalyn J Singleton; Thomas W Hennessy; Lisa R Bulkow; Laura L Hammitt; Tammy Zulz; Debby A Hurlburt; Jay C Butler; Karen Rudolph; Alan Parkinson
Journal:  JAMA       Date:  2007-04-25       Impact factor: 56.272

7.  Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.

Authors:  Lauri A Hicks; Lee H Harrison; Brendan Flannery; James L Hadler; William Schaffner; Allen S Craig; Delois Jackson; Ann Thomas; Bernard Beall; Ruth Lynfield; Arthur Reingold; Monica M Farley; Cynthia G Whitney
Journal:  J Infect Dis       Date:  2007-10-04       Impact factor: 5.226

8.  Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study.

Authors:  James D Kellner; Otto G Vanderkooi; Judy MacDonald; Deirdre L Church; Gregory J Tyrrell; David W Scheifele
Journal:  Clin Infect Dis       Date:  2009-07-15       Impact factor: 9.079

9.  Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life.

Authors:  B M Gray; G M Converse; H C Dillon
Journal:  J Infect Dis       Date:  1980-12       Impact factor: 5.226

10.  Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3 years by various pneumococcal conjugate vaccines.

Authors:  Dror S Shouval; David Greenberg; Noga Givon-Lavi; Nurith Porat; Ron Dagan
Journal:  Pediatr Infect Dis J       Date:  2009-04       Impact factor: 2.129

View more
  13 in total

1.  Noninvasive pneumococcal clones associated with antimicrobial nonsusceptibility isolated from children in the era of conjugate vaccines.

Authors:  Martha McElligott; Imelda Vickers; Mary Meehan; Mary Cafferkey; Robert Cunney; Hilary Humphreys
Journal:  Antimicrob Agents Chemother       Date:  2015-07-13       Impact factor: 5.191

Review 2.  The role of vaccination in preventing pneumococcal disease in adults.

Authors:  S Aliberti; M Mantero; M Mirsaeidi; F Blasi
Journal:  Clin Microbiol Infect       Date:  2014-02-22       Impact factor: 8.067

3.  Demonstration of the herd effect in adults after the implementation of pneumococcal vaccination with PCV13 in children.

Authors:  C Hays; Q Vermee; A Agathine; A Dupuis; E Varon; C Poyart; M-C Ploy; J Raymond
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-12-20       Impact factor: 3.267

4.  Evidence of a clonal expansion of Streptococcus pneumoniae serotype 19A in adults as in children assessed by the DiversiLab® system.

Authors:  O Hurmic; N Grall; M Al Nakib; C Poyart; S Grondin; M-C Ploy; E Varon; J Raymond
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-06-15       Impact factor: 3.267

Review 5.  Pneumococcal Disease in the Era of Pneumococcal Conjugate Vaccine.

Authors:  Inci Yildirim; Kimberly M Shea; Stephen I Pelton
Journal:  Infect Dis Clin North Am       Date:  2015-12       Impact factor: 5.982

6.  Serotype and genotype distribution among invasive Streptococcus pneumoniae isolates in Colombia, 2005-2010.

Authors:  Eliana L Parra; Viviana Ramos; Olga Sanabria; Jaime Moreno
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

7.  Epidemiology of invasive pneumococcal disease in older people in Spain (2007-2009): implications for future vaccination strategies.

Authors:  Carmen Ardanuy; José María Marimón; Laura Calatayud; Montserrat Giménez; Marta Alonso; Immaculada Grau; Román Pallarés; Emilio Pérez-Trallero; Josefina Liñares
Journal:  PLoS One       Date:  2012-08-22       Impact factor: 3.240

8.  One-step multiplex PCR assay for detecting Streptococcus pneumoniae serogroups/types covered by 13-valent pneumococcal conjugate vaccine (PCV13).

Authors:  Fatma Filiz Coskun-Ari; Dilek Guldemir; Riza Durmaz
Journal:  PLoS One       Date:  2012-12-04       Impact factor: 3.240

9.  Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites.

Authors:  Daniel R Feikin; Eunice W Kagucia; Jennifer D Loo; Ruth Link-Gelles; Milo A Puhan; Thomas Cherian; Orin S Levine; Cynthia G Whitney; Katherine L O'Brien; Matthew R Moore
Journal:  PLoS Med       Date:  2013-09-24       Impact factor: 11.069

10.  Insight Into Resistance Phenotypes of Emergent Non 13-valent Pneumococcal Conjugate Vaccine Type Pneumococci Isolated From Invasive Disease After 13-valent Pneumococcal Conjugate Vaccine Implementation in France.

Authors:  Claire Janoir; Agnès Lepoutre; Laurent Gutmann; Emmanuelle Varon
Journal:  Open Forum Infect Dis       Date:  2016-02-02       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.